Canadian Sec - Delayed Quote • CAD
HAVN Life Sciences Inc. (HAVN.CN)
At close: November 9 at 2:12 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Clissold (Gordon Kenneth) Senior Officer of Issuer | Acquisition or disposition in the public market | Apr 1, 2022 | 30,500 |
| Leong (Gary Joseph) Director of Issuer | Exercise of rights | Mar 23, 2022 | 180,000 |
| Moore (Timothy David) Senior Officer of Issuer | Exercise of rights | Mar 16, 2022 | 1,000,000 |
| Neufeld (Victor Rudolf) Director of Issuer | Exercise of rights | Mar 15, 2022 | 3,000,000 |
Related Tickers
IOT.V Innovotech Inc.
0.1300
0.00%
SBTX.L SkinBioTherapeutics plc
9.50
-2.56%
NMLSF Nova Mentis Life Science Corp.
0.0091
0.00%
TRYPF Tryp Therapeutics Inc.
0.0360
+3.75%
DOSE.CN Rapid Dose Therapeutics Corp.
0.2000
0.00%
AGN.CN Algernon Pharmaceuticals Inc.
0.1000
0.00%
HEM.V Hemostemix Inc.
0.0500
-9.09%
NRX.V NurExone Biologic Inc.
0.6000
0.00%
SAR.L Sareum Holdings plc
23.07
-13.75%
PHRM.CN PharmaTher Holdings Ltd.
0.2300
+4.55%